APA (7th ed.) Citation

A, P., A, C., G, M., K, T., K, M., N, P., . . . I, P. (2024). Evaluating the diagnostic and prognostic ability of ischemia modified albumin in COVID-19. Heart & lung : the journal of critical care, 66, 16. https://doi.org/10.1016/j.hrtlng.2024.03.003

Chicago Style (17th ed.) Citation

A, Pagonis, et al. "Evaluating the Diagnostic and Prognostic Ability of Ischemia Modified Albumin in COVID-19." Heart & Lung : The Journal of Critical Care 66 (2024): 16. https://doi.org/10.1016/j.hrtlng.2024.03.003.

MLA (9th ed.) Citation

A, Pagonis, et al. "Evaluating the Diagnostic and Prognostic Ability of Ischemia Modified Albumin in COVID-19." Heart & Lung : The Journal of Critical Care, vol. 66, 2024, p. 16, https://doi.org/10.1016/j.hrtlng.2024.03.003.